Home » Topics » Disease categories and therapies » Dental

Dental
RSS

P2X7 receptor contributes to the hyperinflammatory response of localized aggressive periodontitis

Nov. 6, 2018

Sphingosine 1-phosphate receptor 5 agonists identified at AbbVie

May 23, 2018

Therapix and Rafa sign a memorandum of understanding for venture formation

March 16, 2017

FDA responts to Oragenic's request for type C meeting

Aug. 31, 2016

FDA approves Kovanaze nasal spray for dental anesthesia

July 13, 2016

Fujifilm demonstrates potential of Cellnest in bone regeneration

March 21, 2016

BioMed X and J&J to develop biofilm inhibitors for oral health applications

Jan. 11, 2016

Kaken files application for approval of periodontal regenerative agent KCB-1D

Oct. 5, 2015

A novel modified glycosaminoglycan shows efficacy for mouth disorders

Aug. 18, 2015

C3 Jian completes second phase II study of C16G2

July 14, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 10, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
US lawmakers demand that Kennedy be held accountable
BioWorld
As the systematic dismantling of the U.S. vaccine schedule escalates, the demands to hold Health and Human Services Secretary Robert Kennedy accountable are...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...